FindTrial
Sign In

Role of prucalopride and its effectiveness in bowel preparation for colonoscopy

Role of prucalopride and its effectiveness in bowel preparation for colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016158
Enrollment
Unknown
Registered
2018-05-15
Start date
2016-01-01
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People who receive colonoscopy

Interventions

P-NaP group:Prucalopride
90-NaP group:Fleet

Sponsors

Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who came to gastroenterology outpatient department for diagnostic colonoscopy were eligible for the study: 1. Patients had to be aged 20 to 65 years old, willing and able to complete the entire procedure after given written informed consent according to the Declaration of Helsinki; 2. Consent to publish and report individual data from all the patients were also obtained.

Exclusion criteria

Exclusion criteria: 1. Acute and/or chronic renal failure; 2. Congestive heart failure (in any NYHA grade); 3. Unstable angina; 4. Liver cirrhosis; 5. Toxic or congenital megacolon; 6. Intestinal obstruction; 7. Bowel perforation; 8. History of abdominal surgery (involving gastrointestinal tract, uterine, or liver); 9. Psychiatry disorders.

Design outcomes

Primary

MeasureTime frame
efficacy of colon preparation;—

Countries

China

Contacts

Public ContactChih-Hsun Yi

Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

chihhsunyi@gmail.com+886 3 8561825-13224

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026